Evidence map›Paper›PMID 35148974›Full record

ArticleArchives of cardiovascular diseases2022

Echocardiography and renin-aldosterone interplay as predictors of death in COVID-19.

Joe-Elie Salem, Nadjib Hammoudi, Bruno Pinna, Stephane Ederhy, Antonin Lamazière, Charlotte Fenioux, Alban Redheuil, Pierre Salem, Claire Ribet, Omar Hamwy and 12 more

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of cardiovascular diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 2 institutions in 1 country.

Joe-Elie SalemCIC-1901 and Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France. Electronic address: joe-elie.salem@aphp.fr.
Nadjib HammoudiSorbonne Université, ACTION Study Group, Inserm UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), boulevard de l'hôpital, 75013 Paris, France.
Bruno PinnaCIC-1901 and Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France.
Stephane EderhyDepartment of Cardiology, Saint-Antoine Hospital, AP-HP, Sorbonne Université, 75012 Paris, France.
Antonin LamazièreDepartment of Clinical Metabolomics, Saint-Antoine Hospital, AP-HP, Sorbonne Université, 75012 Paris, France.
Charlotte FeniouxCIC-1901 and Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France.
Alban RedheuilDepartment of Radiology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, 75013 Paris, France.
Pierre SalemCIC-1901 and Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France.
Claire RibetCIC-1901 and Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France.
Omar HamwyCIC-1901 and Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France.
Anne-Geneviève MarcelinService de Virologie, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France.
Sonia BurrelService de Virologie, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Hôpital Pitié-Salpêtrière, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France.
Christian Funck-BrentanoCIC-1901 and Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France.
Gilles MontalescotSorbonne Université, ACTION Study Group, Inserm UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), boulevard de l'hôpital, 75013 Paris, France.
Jean-Marc LacorteDepartment of Endocrine and Oncological Biochemistry, Research Unit on Cardiovascular and Metabolic Disease, UMR ICAN, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Inserm, 75013 Paris, France.
Estelle GandjbakhchSorbonne Université, ACTION Study Group, Inserm UMR_S 1166, Institute of Cardiometabolism And Nutrition (ICAN), and Hôpital Pitié-Salpêtrière (AP-HP), boulevard de l'hôpital, 75013 Paris, France.
Olivier BenvenisteDepartment of Internal Medicine, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, 75013 Paris, France.
David SaadounDepartment of Internal Medicine, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, 75013 Paris, France.
Yves AllenbachDepartment of Internal Medicine, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, 75013 Paris, France.
Samia BoussouarDepartment of Radiology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, 75013 Paris, France.
Edi PriftiIRD, UMMISCO, Sorbonne Université, 93143 Bondy, France.
Patrice CacoubDepartment of Internal Medicine, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, 75013 Paris, France.
Inserm · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19EchocardiographyRenin-Angiotensin SystemAldosteroneBiomarkersHumansSARS-CoV-2AldosteroneBiomarkersAldosteroneAldostéroneBiomarkersBiomarqueursCOVID-19ÉchocardiographieEchocardiographyPrognosis

Identifiers

PMID35148974
PMCPMC8809659
OpenAlexW4210461907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.